TY - JOUR JO - Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej SN - 1734-9338 VL - 12 IS - 2 PY - 2016 ID - Bagienski2016 TI - Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry AB - Introduction : Transcatheter aortic valve implantation (TAVI) is a less invasive treatment option for elderly, high-risk patients with symptomatic severe aortic stenosis (AS) than aortic valve replacement. More importantly, TAVI improves survival and quality of life as compared to medical treatment in inoperable patients. Aim: To assess early- and mid-term clinical outcomes after TAVI. Material and methods: All consecutive high-risk patients with severe symptomatic AS undergoing TAVI from November 2008 to August 2014 were enrolled. The clinical and procedural characteristics, as well as clinical outcomes including mortality during 12-month follow-up, were assessed. Results : A total of 101 consecutive patients underwent TAVI for native aortic valve stenosis (100%). Patients were elderly, with a median age of 81.0 (76.0–84.0) years, 60.4% were female and 83.2% presented with NYHA III/IV. Median baseline EuroSCORE I and STS scores were 14.0 (10.0–22.5)% and 12.0 (5.0–24.0)%, respectively. The main periprocedural and in-hospital complications were minor vascular complications, bleeding requiring blood transfusions, and the need for a permanent pacemaker. In-hospital, 30-day, 6-month and 12-month mortality rates were 6.9%, 10.9%, 15.8% and 17.8%, respectively. Conclusions : A mortality rate of < 20% after 12 months seems acceptable given the high-risk population enrolled. AU - Bagienski, Maciej AU - Kleczynski, Pawel AU - Dziewierz, Artur AU - Rzeszutko, Lukasz AU - Sorysz, Danuta AU - Trebacz, Jaroslaw AU - Sobczynski, Robert AU - Tomala, Marek AU - Stapor, Maciej AU - Gackowski, Andrzej AU - Dudek, Dariusz SP - 122 EP - 127 DA - 2016 DO - 10.5114/aic.2016.59362 UR - http://dx.doi.org/10.5114/aic.2016.59362 ER -